Xiao‐Han Gao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Xiao‐Han Gao has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Jie Yang
Department of Hematology Hebei General Hospital Shijiazhuang China
5 shared publicationsJie Li
Hebei General Hospital Affiliated to Hebei Medicine University
4 shared publicationsYan Li
Department of Hematology Hebei General Hospital Shijiazhuang China
4 shared publicationsHongling Hao
Hebei General Hospital
2 shared publicationsJing Li
Hebei Province Chinese Medicine Hospital
2 shared publicationsLin Kang
Hebei General Hospital
2 shared publications
Latest Publications
- Open Access
- 5 March 2025
- Published by Wiley in Cancer Reports
- Vol. 8 (3) , e70151
Exploration of the Prognostic Markers of Multiple Myeloma Based on Cuproptosis‐Related Genes
Background: The investigation of cuproptosis in relation to tumor development has been limited, particularly in multiple myeloma (MM), indicating the need for further research. Our study aimed to examine the impact of cuproptosis‐related genes (CRGs) on the prognosis of MM.Methods: Using the datasets, we filtered cuproptosis score‐related differentially expressed genes (CRDEGs) by overlapping the DEGs between the MM and normal groups and between the high and low cuproptosis score groups. Additionally, key module genes were identified through weighted gene co‐expression network analysis. A univariate Cox algorithm and multivariate Cox analysis were employed to obtain biomarkers of MM and build a prognostic model before conducting independent prognostic analysis.Results: A total of 59 CRDEGs were filtered, demonstrating their involvement in the COPII vesicle coat and endoplasmic reticulum protein processing, and protein processing in the endoplasmic reticulum. Six prognosis‐related biomarkers (PARP1, EDEM3, SEC23A, RSL24D1, TTC37, and SRP72) were obtained, and a prognostic model was developed. The performance of the model was verified using a test cohort (GSE136324 dataset) and a validation cohort (GSE24080 dataset). Risk score, age, albumin, International Staging System (ISS) score, and β2‐microglobulin (B2M) were found to be significant predictors of prognosis independently.Conclusion: As a result of this investigation, a set of six biomarkers associated with cuproptosis (PARP1, EDEM3, SEC23A, RSL24D1, TTC37, and SRP72) were screened to provide a basis for predicting the prognosis of MM.
- 5 March 2025
- Published by Wiley in Cancer Reports
- Vol. 8 (3) , e70151
Open AccessExploration of the Prognostic Markers of Multiple Myeloma Based on Cuproptosis‐Related Genes
Background: The investigation of cuproptosis in relation to tumor development has been limited, particularly in multiple myeloma (MM), indicating the need for further research. Our study aimed to examine the impact of cuproptosis‐related genes (CRGs) on the prognosis of MM.Methods: Using the datasets, we filtered cuproptosis score‐related differentially expressed genes (CRDEGs) by overlapping the DEGs between the MM and normal groups and between the high and low cuproptosis score groups. Additionally, key module genes were identified through weighted gene co‐expression network analysis. A univariate Cox algorithm and multivariate Cox analysis were employed to obtain biomarkers of MM and build a prognostic model before conducting independent prognostic analysis.Results: A total of 59 CRDEGs were filtered, demonstrating their involvement in the COPII vesicle coat and endoplasmic reticulum protein processing, and protein processing in the endoplasmic reticulum. Six prognosis‐related biomarkers (PARP1, EDEM3, SEC23A, RSL24D1, TTC37, and SRP72) were obtained, and a prognostic model was developed. The performance of the model was verified using a test cohort (GSE136324 dataset) and a validation cohort (GSE24080 dataset). Risk score, age, albumin, International Staging System (ISS) score, and β2‐microglobulin (B2M) were found to be significant predictors of prognosis independently.Conclusion: As a result of this investigation, a set of six biomarkers associated with cuproptosis (PARP1, EDEM3, SEC23A, RSL24D1, TTC37, and SRP72) were screened to provide a basis for predicting the prognosis of MM.
- Open Access
- 1 September 2024
- Published by Wiley
Exploration of the prognostic markers of multiple myeloma based on cuproptosis-related genes
Not-yet-known not-yet-known not-yet-known unknown Background: The investigation of cuproptosis in relation to tumor development has been limited, particularly in Multiple myeloma (MM), indicating the need for further research. Our study aimed to examine the impact of cuproptosis-related genes on the prognosis of MM. Methods: Using the datasets, we filtered cuproptosis score-related differentially expressed genes (CRDEGs) by overlapping the DEGs between the MM and normal groups and between the high and low cuproptosis score groups. Additionally, key module genes were identified through weighted gene co-expression network analysis. A univariate Cox algorithm and multivariate Cox analysis were employed to obtain biomarkers of MM and build a prognostic model, before conducting independent prognostic analysis. Results: A total of 59 CRDEGs were filtered. Demonstrating their involvement in the COPII vesicle coat and endoplasmic reticulum protein processing and protein processing in the endoplasmic reticulum. Six prognosis-related biomarkers (PARP1, EDEM3, SEC23A, RSL24D1, TTC37, and SRP72) were obtained, and a prognostic model was developed. The performance of the model was verified using a test cohort (GSE136324 dataset) and a validation cohort (GSE24080 dataset). Risk score, age, albumin, International Staging System (ISS) score, and β2-microglobulin (B2M) was found to be a significant predictor of prognosis independently . Conclusion: As a result of this investigation, a set of six biomarkers associated with cuproptosis (PARP1, EDEM3, SEC23A, RSL24D1, TTC37 and SRP72) were screened to provide a basis for predicting the prognosis of MM.
- 1 September 2024
- Published by Wiley
Open AccessExploration of the prognostic markers of multiple myeloma based on cuproptosis-related genes
Not-yet-known not-yet-known not-yet-known unknown Background: The investigation of cuproptosis in relation to tumor development has been limited, particularly in Multiple myeloma (MM), indicating the need for further research. Our study aimed to examine the impact of cuproptosis-related genes on the prognosis of MM. Methods: Using the datasets, we filtered cuproptosis score-related differentially expressed genes (CRDEGs) by overlapping the DEGs between the MM and normal groups and between the high and low cuproptosis score groups. Additionally, key module genes were identified through weighted gene co-expression network analysis. A univariate Cox algorithm and multivariate Cox analysis were employed to obtain biomarkers of MM and build a prognostic model, before conducting independent prognostic analysis. Results: A total of 59 CRDEGs were filtered. Demonstrating their involvement in the COPII vesicle coat and endoplasmic reticulum protein processing and protein processing in the endoplasmic reticulum. Six prognosis-related biomarkers (PARP1, EDEM3, SEC23A, RSL24D1, TTC37, and SRP72) were obtained, and a prognostic model was developed. The performance of the model was verified using a test cohort (GSE136324 dataset) and a validation cohort (GSE24080 dataset). Risk score, age, albumin, International Staging System (ISS) score, and β2-microglobulin (B2M) was found to be a significant predictor of prognosis independently . Conclusion: As a result of this investigation, a set of six biomarkers associated with cuproptosis (PARP1, EDEM3, SEC23A, RSL24D1, TTC37 and SRP72) were screened to provide a basis for predicting the prognosis of MM.
- Open Access
- 31 January 2024
- Published by Wiley
Misdiagnosed of Angioimmunoblastic T-cell lymphoma:a case report
Angioimmunoblastic T-cell lymphoma (AITL) is a special subtype of peripheral T-cell lymphoma. Pathology diagnosis is the gold standard, but due to lack of specific pathological characteristics, diagnosis is challenging. This study had shown that combining immunohistochemistry and gene rearrangement can increase the diagnostic accuracy.
- 31 January 2024
- Published by Wiley
Open AccessMisdiagnosed of Angioimmunoblastic T-cell lymphoma:a case report
Angioimmunoblastic T-cell lymphoma (AITL) is a special subtype of peripheral T-cell lymphoma. Pathology diagnosis is the gold standard, but due to lack of specific pathological characteristics, diagnosis is challenging. This study had shown that combining immunohistochemistry and gene rearrangement can increase the diagnostic accuracy.
- Open Access
- 23 January 2023
- Published by Wiley in Clinical Case Reports
- Vol. 11 (1) , e6827
A rare case of pancytopenia causing‐ Sheehan's syndrome: Case report and literature review
We describe the case of a 58‐year‐old woman who was presented with pancytopenia and hypofibrinogenemia. Treatment with iron supplementation was not satisfactory. Physical findings and a history of a massive postpartum hemorrhage suggested Sheehan's syndrome(SS). After thyroxine and glucocorticoid replacement therapy, the blood cell count improved. SS is a rare etiology of hemocytopenia, of which hematologists need to be aware. We conclude that hormonal therapy can produce full hematological recovery.
- 23 January 2023
- Published by Wiley in Clinical Case Reports
- Vol. 11 (1) , e6827
Open AccessA rare case of pancytopenia causing‐ Sheehan's syndrome: Case report and literature review
We describe the case of a 58‐year‐old woman who was presented with pancytopenia and hypofibrinogenemia. Treatment with iron supplementation was not satisfactory. Physical findings and a history of a massive postpartum hemorrhage suggested Sheehan's syndrome(SS). After thyroxine and glucocorticoid replacement therapy, the blood cell count improved. SS is a rare etiology of hemocytopenia, of which hematologists need to be aware. We conclude that hormonal therapy can produce full hematological recovery.
- Open Access
- 21 August 2021
- Published by Wiley
Angioimmunoblastic T-cell lymphoma combined with Hodgkin’s lymphoma:a case report
Angioimmunoblastic T-cell lymphoma (AITL) is a special subtype of peripheral T-cell lymphoma, Histopathological examination is the main basis for the diagnosis of the disease, but the diagnosis is challenging. The study has shown that combining immunohistochemistry and gene rearrangement can increase the diagnostic accuracy
- 21 August 2021
- Published by Wiley
Open AccessAngioimmunoblastic T-cell lymphoma combined with Hodgkin’s lymphoma:a case report
Angioimmunoblastic T-cell lymphoma (AITL) is a special subtype of peripheral T-cell lymphoma, Histopathological examination is the main basis for the diagnosis of the disease, but the diagnosis is challenging. The study has shown that combining immunohistochemistry and gene rearrangement can increase the diagnostic accuracy